Physiologic effect of high-flow nasal cannula in infants with bronchiolitis

Judith L Hough1, Trang M T Pham, Andreas Schibler

  • 11Paediatric Critical Care Research Group, Paediatric Intensive Care Unit, Mater Children's Hospital, South Brisbane, QLD, Australia. 2School of Physiotherapy, Australian Catholic University, Banyo, QLD, Australia. 3Critical Care of the Newborn Program, Mater Research, South Brisbane, QLD, Australia.

Insights

High-flow nasal cannula (HFNC) therapy at 8 L/min significantly increased lung volume and improved oxygenation in infants with bronchiolitis. This finding supports higher flow rates for better respiratory support in young children.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory physiology
  • Neonatology and infant respiratory support

Background:

  • Bronchiolitis is a common respiratory infection in infants, often requiring respiratory support.
  • High-flow nasal cannula (HFNC) therapy is increasingly used for respiratory distress in infants.
  • Understanding the physiological effects of HFNC in bronchiolitis is crucial for optimizing treatment.

Purpose of the Study:

  • To evaluate the impact of different high-flow nasal cannula (HFNC) flow rates on lung volumes and ventilation distribution.
  • To assess the effect of HFNC on continuous distending pressure and physiological parameters in infants with bronchiolitis.

Main Methods:

  • A prospective observational study was conducted in a pediatric intensive care unit (PICU).
  • Thirteen infants diagnosed with bronchiolitis received HFNC at flow rates of 2 L/min and 8 L/min.
  • Electrical impedance tomography (EIT) was used to measure end-expiratory lung volume and ventilation distribution.

Main Results:

  • Delivering HFNC at 8 L/min significantly increased global and anterior end-expiratory lung volumes compared to 2 L/min (p < 0.01).
  • Higher flow rates also led to improvements in respiratory rate, oxygen saturation (SpO2), and fraction of inspired oxygen (FIO2).
  • Continuous distending pressure changes were monitored via nasogastric tube.

Conclusions:

  • In infants with bronchiolitis, HFNC delivered at 8 L/min effectively increases end-expiratory lung volume.
  • Higher HFNC flow rates improve key physiological parameters including respiratory rate, SpO2, and FIO2.
  • These findings suggest that 8 L/min of HFNC is beneficial for managing respiratory distress in infants with bronchiolitis.
Abstract

Related Concept Videos

Administering Oxygen by Nasal Cannula01:29

Administering Oxygen by Nasal Cannula

Oxygen therapy is critical to patient care, especially for those struggling with respiratory issues. This intervention increases the oxygen concentration in the lungs, enhancing the amount of oxygen transported to the body's tissues. One standard method of delivering supplemental oxygen is through a nasal cannula, a non-invasive device that provides low to medium oxygen concentrations.
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
6.1K
Oxygen Delivering System I: Nasal Cannula and Face Mask01:26

Oxygen Delivering System I: Nasal Cannula and Face Mask

The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
2.7K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
931
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
50.6K